Part,  Chapter, Paragraph

1   II,     5.  5.  3|     month prospective analysis. Pharmacoeconomics 14(3):299-312.~Dorsey ER,
2   II,     5.  5.  3|       with Parkinson’s disease. Pharmacoeconomics 16(1):59-69.~Lindgren P,
3   II,     5.  5.  3| Parkinson’s disease in Germany. Pharmacoeconomics 23(8):817-836.~Sutcliffe
4   II,     5.  9.  7|    Editors. Quality of Life and Pharmacoeconomics in Cinical Trials. Philadelphia:
5   IV,    11.  6.  5|       Europe." Expert Review of Pharmacoeconomics & Outcomes Research 5(1):